File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Simultaneous or staged installation with guided bone augmentation of transmucosal titanium implants: A 3-year prospective cohort study

TitleSimultaneous or staged installation with guided bone augmentation of transmucosal titanium implants: A 3-year prospective cohort study
Authors
Issue Date2003
PublisherWiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CLR
Citation
Clinical Oral Implants Research, 2003, v. 14 n. 6, p. 680-686 How to Cite?
AbstractA prospective cohort study of 45 nonsmoking consecutively admitted patients was studied for the treatment outcomes following jaw bone augmentation in conjunction with installment of oral implants. Twenty-eight patients were treated for both bone augmentation and implant treatment simultaneously, while 17 patients were treated with a staged approach with the bone augmentation being performed 6-8 months prior to implant installation. Three months following this, prosthetic reconstructions were incorporated. One year thereafter, baseline data and 3 years after reconstruction, follow-up data were obtained. Moderately low mean scores for the bleeding on probing percentage were found at baseline (24%) and after 3 years of function (17%), while the corresponding values at the implant sites were 40.6% and 52.4%, respectively. However, the modified gingival index (mGI) = 2 was found in only 4.8%, and 6.9% at the baseline and 3-year examinations. Peri-implant Probing depth (PPD) and level of attachment mean values did not vary between baseline and follow-up examinations. Only a small proportion of 1.8% yielded PPD = 6.0 mm after 3 years of function. Radiographic bone level measurements showed that 18.2% of the implants lost 0.5 mm during the observation period. Seventy percent of the sites were considered completely stable. It was concluded that predictable treatment outcomes resulted for oral implant installation combined with or staged after jawbone augmentation. Only 6.5% of the sites had lost 1.5% crestal bone with the staged approach while 14% of the sites had lost 1.5 mm, when the implants were placed simultaneously. This suggests that the staged approach may have a lower risk for greater amounts of crestal bone loss as the simultaneous approach. In general, crestal bone loss encountered in the present study corresponded very well with that reported following placement of the same implant system into nonaugmented bone.
Persistent Identifierhttp://hdl.handle.net/10722/154262
ISSN
2015 Impact Factor: 3.464
2015 SCImago Journal Rankings: 1.427
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorChristensen, DKen_US
dc.contributor.authorKaroussis, IKen_US
dc.contributor.authorJoss, Aen_US
dc.contributor.authorHämmerle, CHFen_US
dc.contributor.authorLang, NPen_US
dc.date.accessioned2012-08-08T08:24:17Z-
dc.date.available2012-08-08T08:24:17Z-
dc.date.issued2003en_US
dc.identifier.citationClinical Oral Implants Research, 2003, v. 14 n. 6, p. 680-686en_US
dc.identifier.issn0905-7161en_US
dc.identifier.urihttp://hdl.handle.net/10722/154262-
dc.description.abstractA prospective cohort study of 45 nonsmoking consecutively admitted patients was studied for the treatment outcomes following jaw bone augmentation in conjunction with installment of oral implants. Twenty-eight patients were treated for both bone augmentation and implant treatment simultaneously, while 17 patients were treated with a staged approach with the bone augmentation being performed 6-8 months prior to implant installation. Three months following this, prosthetic reconstructions were incorporated. One year thereafter, baseline data and 3 years after reconstruction, follow-up data were obtained. Moderately low mean scores for the bleeding on probing percentage were found at baseline (24%) and after 3 years of function (17%), while the corresponding values at the implant sites were 40.6% and 52.4%, respectively. However, the modified gingival index (mGI) = 2 was found in only 4.8%, and 6.9% at the baseline and 3-year examinations. Peri-implant Probing depth (PPD) and level of attachment mean values did not vary between baseline and follow-up examinations. Only a small proportion of 1.8% yielded PPD = 6.0 mm after 3 years of function. Radiographic bone level measurements showed that 18.2% of the implants lost 0.5 mm during the observation period. Seventy percent of the sites were considered completely stable. It was concluded that predictable treatment outcomes resulted for oral implant installation combined with or staged after jawbone augmentation. Only 6.5% of the sites had lost 1.5% crestal bone with the staged approach while 14% of the sites had lost 1.5 mm, when the implants were placed simultaneously. This suggests that the staged approach may have a lower risk for greater amounts of crestal bone loss as the simultaneous approach. In general, crestal bone loss encountered in the present study corresponded very well with that reported following placement of the same implant system into nonaugmented bone.en_US
dc.languageengen_US
dc.publisherWiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CLRen_US
dc.relation.ispartofClinical Oral Implants Researchen_US
dc.subject.meshAlveolar Bone Loss - Radiography - Surgeryen_US
dc.subject.meshAlveolar Process - Physiopathology - Radiographyen_US
dc.subject.meshAlveolar Ridge Augmentation - Methodsen_US
dc.subject.meshBone Regeneration - Physiologyen_US
dc.subject.meshBone Transplantation - Radiographyen_US
dc.subject.meshCohort Studiesen_US
dc.subject.meshDental Implantation, Endosseous - Methodsen_US
dc.subject.meshDental Implants, Single-Toothen_US
dc.subject.meshDental Plaque Indexen_US
dc.subject.meshDental Prosthesis Retentionen_US
dc.subject.meshDental Prosthesis, Implant-Supporteden_US
dc.subject.meshFollow-Up Studiesen_US
dc.subject.meshGuided Tissue Regeneration, Periodontal - Methodsen_US
dc.subject.meshHumansen_US
dc.subject.meshMembranes, Artificialen_US
dc.subject.meshOsseointegration - Physiologyen_US
dc.subject.meshProspective Studiesen_US
dc.subject.meshTime Factorsen_US
dc.subject.meshTitaniumen_US
dc.subject.meshTreatment Outcomeen_US
dc.titleSimultaneous or staged installation with guided bone augmentation of transmucosal titanium implants: A 3-year prospective cohort studyen_US
dc.typeArticleen_US
dc.identifier.emailLang, NP:nplang@hkucc.hku.hken_US
dc.identifier.authorityLang, NP=rp00031en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1046/j.0905-7161.2003.00963.xen_US
dc.identifier.pmid15015942-
dc.identifier.scopuseid_2-s2.0-0346850732en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0346850732&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume14en_US
dc.identifier.issue6en_US
dc.identifier.spage680en_US
dc.identifier.epage686en_US
dc.identifier.isiWOS:000187107700002-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridChristensen, DK=7201639997en_US
dc.identifier.scopusauthoridKaroussis, IK=6603174242en_US
dc.identifier.scopusauthoridJoss, A=7005904584en_US
dc.identifier.scopusauthoridHämmerle, CHF=7005331848en_US
dc.identifier.scopusauthoridLang, NP=7201577367en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats